Literature DB >> 8996849

Sulthiame-associated mild compensated metabolic acidosis.

U Tröger1, C Fritzsch, J Darius, J Gedschold, F P Meyer.   

Abstract

Sulthiame is effectively used in the treatment of benign and symptomatic focal epilepsy in children. Hyperventilation as a symptom is a well known adverse effect of the drug. Alterations of the acid-base equilibrium have been described for the drug, however, very infrequently only in adults without a detailed evaluation of the disorders status. The case presented here demonstrates a mild compensated metabolic acidosis in a child which, for the first time, is described using the methods of complete blood gas and electrolytes analysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8996849

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  2 in total

1.  Sulthiame impairs mitochondrial function in vitro and may trigger onset of visual loss in Leber hereditary optic neuropathy.

Authors:  Marie-Christine Reinert; David Pacheu-Grau; Claudia B Catarino; Thomas Klopstock; Andreas Ohlenbusch; Michael Schittkowski; Ekkehard Wilichowski; Peter Rehling; Knut Brockmann
Journal:  Orphanet J Rare Dis       Date:  2021-02-04       Impact factor: 4.123

2.  Stability-Indicating High-Performance Liquid Chromatography Assay for the Determination of Sulthiame in Pharmaceutical Dosage Forms.

Authors:  Ammar Haidar; Sofiane Kabiche; Elyes Majoul; Issa-Bella Balde; Jean-Eudes Fontan; Salvatore Cisternino; Joël Schlatter
Journal:  Anal Chem Insights       Date:  2016-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.